A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

Inclusion Criteria:

The main inclusion criteria include but are not limited to the following:

• Has compensated cirrhosis caused by metabolic dysfunction-associated steatohepatitis (MASH)

• Has either type 2 diabetes that is controlled by diet or medication, or does nothave type 2 diabetes

Exclusion Criteria:

The main exclusion criteria include but are not limited to the following:

• Has history of a liver disease other than MASH, for example, Hepatitis B or C,drug-induced liver disease, or autoimmune liver disease

• Has history of type 1 diabetes

• Had a bariatric surgical procedure less than 5 years before entry into the study

• History of pancreatitis

• Major illnesses like recent (within 6 months of study entry) episodes of heartproblems, such as congestive heart failure, unstable angina, heart attack, stroke,or mini-stroke